Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure.

BACKGROUND We describe the performance of an implantable hemodynamic monitor (IHM) that allows continuous recording of heart rate, patient activity levels, and right ventricular systolic, right ventricular diastolic, and estimated pulmonary artery diastolic pressures. Pressure parameters derived from the implantable monitor were correlated to measurements made with a balloon-tipped catheter to establish accuracy and reproducibility over time in patients with chronic heart failure (CHF). METHODS AND RESULTS IHM devices were implanted in 32 patients with CHF (left ventricular ejection fraction, 29% +/- 11%; range, 14%-62%) and were tested with right heart catheterization at implantation and 3, 6, and 12 months later. Hemodynamic variables were digitally recorded simultaneously from the IHM and catheter. Values were recorded during supine rest, peak response of Valsalva maneuver, sitting, peak of a 2-stage (25-50 W) bicycle exercise test, and final rest period. The median of 21 paired beat-to-beat cardiac cycles was analyzed for each intervention. A total of 217 paired data values from all maneuvers were analyzed for 32 patients at implantation and 129 paired data values for 20 patients at 1 year. The IHM and catheter values were not different at baseline or at 1 year (P >.05). Combining all interventions, correlation coefficients were 0.96 and 0.94 for right ventricular systolic pressure, 0.96 and 0.83 for right ventricular diastolic pressure, and 0.87 and 0.87 for estimated pulmonary artery diastolic pressure at implantation and 1 year, respectively. CONCLUSIONS The IHM and a standard reference pressure system recorded comparable right heart pressure values in patients with CHF. This implantable pressure transducer is accurate over time and provides a means to precisely monitor the hemodynamic condition of patients with CHF in a continuous fashion.

[1]  H. Krumholz,et al.  Quality of care for patients hospitalized with heart failure at academic medical centers. , 1999, American heart journal.

[2]  M. Drazner,et al.  Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  J. O’Keefe,et al.  Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure , 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[4]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[5]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[6]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[7]  P. Poole‐Wilson,et al.  Diurnal variation of pulmonary artery pressure in chronic heart failure. , 1989, British heart journal.

[8]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  D. Reynolds,et al.  Measurement of pulmonary artery diastolic pressure from the right ventricle. , 1995, Journal of the American College of Cardiology.

[10]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[11]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[12]  L. Rydén,et al.  Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. , 1995, Journal of cardiac failure.

[13]  W. Stevenson,et al.  Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. , 1995, Journal of the American College of Cardiology.

[14]  L. Rydén,et al.  Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. , 1998, European heart journal.

[15]  K M Kessler,et al.  Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. , 1991, The American journal of medicine.

[16]  F. Ottenhoff,et al.  Long-term recording of cardiac output via an implantable haemodynamic monitoring device. , 1996, European heart journal.

[17]  V. Hasselblad,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. , 2001, American heart journal.

[18]  S Adler,et al.  Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. , 2001, European heart journal.

[19]  P. Poole‐Wilson,et al.  Pulmonary artery pressure and activities in chronic heart failure , 1990 .

[20]  L. Stevenson Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[22]  D. Bresnahan,et al.  Initial experience with an implantable hemodynamic monitor. , 1996, Circulation.